Search
Now showing items 1-8 of 8
Marine compounds in the treatment of Alzheimer’s disease
(Brac University, 2022-03)
Brain shrinkage and cell death occurs due to Alzheimer's disease, a degenerative neurologic illness. Memory loss, social and behavioral deterioration, and the inability to operate independently are all symptoms of Alzheimer's ...
Emerging therapies of Alzheimer’s disease: a comprehensive review
(Brac University, 2022-11)
Alzheimer’s disease is a complex, debilitating neurodegenerative disorder, with a rapidly increasing worldwide prevalence. Despite decades of intense research, therapeutics for Alzheimer's disease are still limited to ...
Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
(Brac University, 2022-03)
Alzheimer's disease is a fatal illness that primarily affects older generations; its pathology pathways include beta-amyloid, tau protein, and activated microglia, destruction of synapse and no disease-modifying medication ...
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
(Brac University, 2022-10-30)
Rivastigmine is an anti-cholinesterase agent, used to treat mild to moderate dementia of
Alzheimer’s disease (AD). Its efficacy and tolerability increase the treatment compliance. This
study focused on determining the ...
Epigenetic dysregulation in neurodegenerative diseases and potential treatment
(Brac University, 2022-04)
Epigenetics holds significant relevance in the contemporary neuroscience and has been associated with the pathogenesis of different neurodegenerative disorders. Epigenetic modifications including DNA methylation and histone ...
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
(Brac University, 2022-04)
A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even
though it is the leading motive of dementia in the modern era. The community of patients with
AD leads to expansion. Anxiety, anger, ...
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
(Brac University, 2022-04)
Purpose: Alzheimer's disease (AD) is a multifactorial neurodegenerative brain disorder that affects approximately 5.3 million people in the United States, including nearly half of the population aged 85 and up. It has ...
Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
(Brac University, 2022-11)
In neurology, Alzheimer's disease represents greatest unmet medical need. Formation of
neurofibrillary tangles, Amyloid Beta-peptide (Aβ) deposition, and significant oxidative
stress, synapse loss are features of the ...